BOSTON – Scilligence, an innovation leader of unified informatics platform for biologics and small molecules drug R&D, has partnered with Certara to enable advanced data analysis and visualization capabilities. The companies worked together to integrate Certara’s D360 with Scilligence’s RegMol system. The partnership will help current and future clients to better visualize their scientific research data. […]
New extension enables researchers to explore the REAL Space of 11 billion readily accessible compounds directly from StarDrop CAMBRIDGE, UK, KIEV, UKRAINE and SANKT AUGUSTIN, GERMANY – Optibrium™, BioSolveIT™ and Enamine™, leading providers of software and services for drug discovery, today announce a three-way collaboration enabling efficient search of Enamine’s REAL Space directly from within Optibrium’s […]
Collaboration between drug companies and contract research partners drives innovation in evolving business environment. Columbus, Ohio – CAS, a division of the American Chemical Society, announced today that leading contract research, development and manufacturing organization (CRO/CDMO) BioDuro has signed a five-year agreement for SciFindern. This agreement provides enterprise-wide access to the most advanced scientific information solution […]
Novel features include a unique pKa model, combining quantum mechanics and machine learning methods, and extended capabilities in structure-based design CAMBRIDGE, UK – Optibrium™, a developer of software for drug discovery, today announced the introduction of StarDrop™ 6.6, the latest version of this comprehensive software platform for small molecule design, optimisation and data analysis. The enhanced […]
CAMBRIDGE, UK, 10 October, 2019 – Optibrium™, a developer of software for drug discovery, today announced the introduction of its Augmented Chemistry™ services, which provide collaborators with novel artificial intelligence technologies to supplement their skills and experience, enabling them to make more effective decisions and advance their drug discovery projects. In discovery projects, it is important […]
NEW YORK – Schrödinger today announced a collaboration with AstraZeneca to deploy Schrödinger’s advanced computing platform to help accelerate drug discovery efforts. Schrödinger’s computational platform combines physics-based modeling and machine learning to enable chemists to predict the potency of a molecule binding to a target protein. This increases the likelihood that, when synthesized, compounds will have […]
NEW YORK and AMSTERDAM – Schrödinger and Qu & Co today announced a business and scientific collaboration to advance the use of quantum mechanics on complex molecular systems using quantum computing hardware. Quantum mechanical simulations have become a powerful tool to accelerate materials science and design, but executing the same computations on quantum computers so far […]
ChemAxon and Research Space are pleased to announce the development of a prototype for direct assay data upload from RSpace ELN to ChemAxon Assay. RSpace is an electronic lab notebook used to collect, organize and present life sciences research data, and is distinguished by its flexibility in supporting a variety of workflows, strong support for traceability, and […]
We are pleased to announce Schrödinger software release 2019-3, which is available for download now. This quarterly release includes usability improvements and performance enhancements across all of our software. Click here to learn more about new features in 2019-3.
CDD Vault will support Voronoi’s collaborative research on Kinase Inhibitor and TPD INCHEON, South Korea and SAN FRANCISCO, Aug. 23, 2019 /PRNewswire/ — Voronoi, a drug discovery and development biotech company in Korea announced today that it has, after an extensive evaluation process, selected CDD Vault as its platform of choice to manage its drug discovery data and collaborative projects. […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
